To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RSL1D1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
342 supporting clones for gene RSL1D1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_57190140   .a 1 to 805 48 to 852   tiling clone,   805/811
(99 %)
9 diff
(98.9 %id)
BI856275 breast, mammary adenocarcinoma, cell line .a 4 to 805 1 to 802       802/808
(99 %)
9 diff
(98.9 %id)
NM_015659.2   .a 4 to 5140 1 to 5137 exact RefSeq,   5137/5137
(100 %)
0 diff
(100 %id)
DC364760   .a 5 to 774 1 to 769       769/769
(100 %)
1 diff
(99.9 %id)
DA906805   .a 6 to 569 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA984606 synovial membrane tissue from rheumatioidarthritis .a 8 to 569 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AL049999 brain .a 17 to 939 1 to 922   available from DKFZ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 922/949
(97 %)
10 diff
(99.0 %id)
DA003771   .a 18 to 588 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA180610 amygdala .a 18 to 591 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA589477 lung .a 22 to 576 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB501605 hypothalamus .a 23 to 744 1 to 722       722/725
(99 %)
5 diff
(99.4 %id)
BQ436913 melanotic melanoma, skin .a 25 to 838 1 to 820       820/866
(94 %)
13 diff
(98.5 %id)
DB042111 testis .a 27 to 598 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA552812   .a 34 to 599 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA907086   .a 34 to 602 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA908779   .a 34 to 597 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA037036 breast .a 37 to 630 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA040299 bladder .a 37 to 612 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
TI_57189128   .a 37 to 768 48 to 782       735/736
(99 %)
8 diff
(99.0 %id)
TI_59392504   .a 37 to 795 50 to 812       763/931
(81 %)
8 diff
(99.2 %id)
DA693732   .a 37 to 608 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CB998912 Blood vessels - aorta, basilar and artery .a 39 to 781 1 to 746       746/749
(99 %)
6 diff
(99.2 %id)
CN369971 embryonic stem cells, cell lines H1, H7, andH9 .a 40 to 750 1 to 713       713/713
(100 %)
3 diff
(99.6 %id)
BG527540 lung, mucoepidermoid carcinoma .a 41 to 916 1 to 872       872/881
(98 %)
31 diff
(96.5 %id)
BG532079 embryonal carcinoma, testis .a 41 to 927 1 to 905       905/908
(99 %)
24 diff
(97.4 %id)
DB032765 testis .a 43 to 638 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
AY154473 lung .a 45 to 1982 3 to 1940 R50G R294G AAA   1938/1940
(99 %)
10 diff
(99.5 %id)
BC112228 Brain, cerebral cortex and lung, PCR rescuedclones .a 45 to 1624 7 to 1586 exact     1580/1586
(99 %)
7 diff
(99.6 %id)
TI_1243017961   .a 45 to 1151 58 to 1159     Submitted on the opposite strand 1102/1226
(89 %)
23 diff
(98.2 %id)
TI_1243023593   .a 45 to 1115 59 to 1119     Submitted on the opposite strand 1061/1245
(85 %)
20 diff
(98.4 %id)
TI_1242415232   .a 45 to 1130 56 to 1132     Submitted on the opposite strand 1077/1229
(87 %)
19 diff
(98.5 %id)
AI751213 Bone, Hip .a 45 to 538 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
DA226948 brain .a 46 to 609 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA473272   .a 46 to 600 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA914087   .a 46 to 609 2 to 565   capped   564/565
(99 %)
0 diff
(100 %id)
AU107104   .a 47 to 96 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
AU107105   .a 47 to 96 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
DC424204   .a 47 to 868 1 to 819       819/861
(95 %)
8 diff
(99.1 %id)
DA068263 cerebellum .a 48 to 609 2 to 563   capped   562/563
(99 %)
0 diff
(100 %id)
DA202417 brain .a 48 to 621 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA710459   .a 48 to 598 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA910392   .a 48 to 619 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA924248 small intestine .a 48 to 622 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA044265 bladder .a 50 to 613 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BC113699 Brain, cerebral cortex and lung, PCR rescuedclones .a 51 to 1628 1 to 1578 exact     1578/1578
(100 %)
0 diff
(100 %id)
BU159956 eye, retinoblastoma .a 51 to 932 1 to 890       890/896
(99 %)
17 diff
(98.2 %id)
BU155683 melanotic melanoma, skin .a 51 to 890 1 to 850       848/890
(95 %)
17 diff
(98.1 %id)
BC107782 Pooled, 40 cell lines .a 51 to 1446 1 to 1396   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1396/1420
(98 %)
5 diff
(99.7 %id)
DB019196 esophageal, tumor tissue .a 52 to 632 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BC070325 Bone marrow, acute myelogenous leukemia .a 53 to 976 1 to 923   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 923/942
(97 %)
5 diff
(99.5 %id)
CB126801 cervix, Uterine .a 55 to 624 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BC017899 Prostate .a 55 to 976 1 to 921   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 921/947
(97 %)
2 diff
(99.8 %id)
BF677349 Prostate .a 55 to 674 1 to 614   available from MGC,   619/891
(69 %)
76 diff
(91.5 %id)
AU107110   .a 55 to 104 1 to 50       50/50
(100 %)
0 diff
(100 %id)
DC424115 mammary gland .a 55 to 805 1 to 746       746/821
(90 %)
9 diff
(99.0 %id)
DA908613   .a 55 to 616 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA088593 cerebellum .a 56 to 620 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA486760 brain .a 56 to 623 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA629529 Kidney .a 56 to 629 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA632835 Kidney .a 56 to 624 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA664391   .a 56 to 927 2 to 869   capped   868/868
(100 %)
9 diff
(99.0 %id)
DA813197   .a 56 to 604 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA821705 pericardium .a 56 to 607 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA909241   .a 56 to 641 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA912194   .a 56 to 627 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA912780   .a 56 to 620 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA922369 small intestine .a 56 to 631 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA922661 small intestine .a 56 to 609 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB024009 testis .a 56 to 608 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB192682 ovary, tumor tissue .a 56 to 614 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB192855 ovary, tumor tissue .a 56 to 630 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB194128 ovary, tumor tissue .a 56 to 630 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB268280 uterus .a 56 to 625 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
AV718234 hypothalamus .a 57 to 792 1 to 735       735/735
(100 %)
4 diff
(99.5 %id)
DB012193 esophageal, tumor tissue .a 57 to 622 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB461403 testis .a 58 to 711 1 to 655       655/658
(99 %)
8 diff
(98.8 %id)
CV812789 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 58 to 780 1 to 723       723/726
(99 %)
1 diff
(99.9 %id)
DB009613 colon, tumor tissue .a 58 to 622 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CV813425 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 59 to 801 1 to 747       747/892
(83 %)
11 diff
(98.8 %id)
DA784357 brain .a 59 to 625 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA821606 pericardium .a 59 to 630 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DN997006 breast cancer, Mammary gland (cancer tissue) .a 59 to 696 1 to 633       633/633
(100 %)
4 diff
(99.4 %id)
TI_59389621   .a 60 to 902 92 to 940       847/849
(99 %)
20 diff
(97.7 %id)
BQ954746 sciatic nerve .a 61 to 912 1 to 870       868/921
(94 %)
22 diff
(97.7 %id)
CB131016 Liver .a 61 to 617 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DA452892 tongue, tumor tissue .a 62 to 635 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA559228   .a 62 to 617 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA906330   .a 62 to 625 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB018697 esophageal, tumor tissue .a 62 to 626 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA585582 lung .a 64 to 661 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
BC009802 Brain, primitive neuroectodermal .a 65 to 976 1 to 911   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 911/937
(97 %)
4 diff
(99.6 %id)
TI_154180198   .a 65 to 897 76 to 908       833/836
(99 %)
22 diff
(97.4 %id)
DN997354 breast cancer, Mammary gland (cancer tissue) .a 66 to 744 1 to 679       679/679
(100 %)
6 diff
(99.2 %id)
ES309765 scalp interfollicular dermis, skin .a 67 to 454 1 to 388       388/388
(100 %)
3 diff
(99.3 %id)
DR761182 embryonic stem .a 67 to 872 1 to 806       806/806
(100 %)
0 diff
(100 %id)
AU107111   .a 67 to 116 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
AK000822 adipose tissue .a 68 to 1983 9 to 1924 I123V available from FLJ, AAA   1916/1924
(99 %)
9 diff
(99.6 %id)
BF701221 brain, primitive neuroectoderm .a 68 to 805 1 to 729   available from MGC,   729/836
(87 %)
31 diff
(96.3 %id)
BG614026 embryonal carcinoma, testis .a 68 to 918 1 to 847       847/901
(94 %)
22 diff
(97.6 %id)
TI_57241460   .a 68 to 930 29 to 891       863/919
(93 %)
26 diff
(97.2 %id)
DA004397   .a 69 to 652 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA058163 cerebellum .a 69 to 645 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA063288 cerebellum .a 69 to 622 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA560230 heart .a 69 to 623 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA576558   .a 69 to 637 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA906463   .a 69 to 652 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA912081   .a 69 to 647 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA037505   .a 70 to 624 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA046639 bladder .a 70 to 631 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA486652 brain .a 70 to 650 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BE748285 bone marrow, from acute myelogenous leukemia .a 70 to 718 1 to 646       646/705
(91 %)
11 diff
(98.5 %id)
BG770960 adenocarcinoma, Prostate .a 70 to 884 1 to 812       812/821
(98 %)
23 diff
(97.2 %id)
BI117548 lung, small cell carcinoma .a 70 to 764 1 to 714   available from MGC,   714/890
(80 %)
33 diff
(96.3 %id)
CB149530 Liver .a 70 to 636 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DA753954   .a 70 to 626 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA827816 pericardium .a 70 to 654 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA997779   .a 70 to 633 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB092815 testis .a 70 to 621 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG176810 lymph, lymphoma, cell line .a 71 to 812 1 to 740       740/963
(76 %)
13 diff
(98.7 %id)
BC019069 Lung, small cell carcinoma .a 71 to 1982 1 to 1912 exact available from MGC, AAA   1912/1912
(100 %)
1 diff
(100.0 %id)
BM471917 eye, retinoblastoma .a 71 to 932 1 to 865       865/1032
(83 %)
9 diff
(99.2 %id)
AJ007398 placenta .a 72 to 1982 1 to 1908 V486Y Q488S S489R T490P     1908/1908
(100 %)
3 diff
(99.9 %id)
CN369965 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 72 to 801 9 to 740       732/740
(98 %)
9 diff
(98.8 %id)
BG697036 skin .a 72 to 849 1 to 778       778/778
(100 %)
1 diff
(99.9 %id)
BM457785 lymph, lymphoma, cell line .a 72 to 931 1 to 861       861/884
(97 %)
6 diff
(99.4 %id)
BU175573 large cell carcinoma, lung .a 72 to 802 1 to 733       733/867
(84 %)
8 diff
(99.1 %id)
BY994282   .a 72 to 775 22 to 725       704/725
(97 %)
6 diff
(99.2 %id)
CN369958 embryonic stem cells, DMSO-treated H9 cellline .a 73 to 724 10 to 662       653/662
(98 %)
8 diff
(98.8 %id)
AA205858   .a 73 to 936 1 to 854       854/897
(95 %)
32 diff
(96.5 %id)
BQ439828 large cell carcinoma, lung .a 74 to 975 1 to 908       908/913
(99 %)
14 diff
(98.5 %id)
CV808100 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 74 to 847 1 to 777       774/892
(86 %)
8 diff
(99.2 %id)
CX751217 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 74 to 790 1 to 717     Submitted on the opposite strand 717/718
(99 %)
1 diff
(99.9 %id)
CD518401 White Matter .a 74 to 878 1 to 820       818/900
(90 %)
24 diff
(97.4 %id)
CN369966 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 75 to 750 16 to 691       676/691
(97 %)
7 diff
(99.0 %id)
TI_57200585   .a 76 to 848 59 to 831       773/832
(92 %)
9 diff
(99.0 %id)
AY598331   .a 77 to 1549 1 to 1473 exact     1473/1473
(100 %)
0 diff
(100 %id)
BX441934 brain, fetal brain .a 77 to 1084 1 to 999       999/1048
(95 %)
19 diff
(98.2 %id)
BG030459 breast, mammary adenocarcinoma, cell line .a 77 to 905 1 to 835       835/855
(97 %)
33 diff
(96.2 %id)
AL516232 brain, neuroblastoma, neuroblastoma cells .a 78 to 882 1 to 801       801/801
(100 %)
4 diff
(99.6 %id)
BX457426 thymus .a 79 to 1083 1 to 1002       1002/1057
(94 %)
14 diff
(98.7 %id)
BI087514 cervix .a 79 to 774 1 to 696       696/697
(99 %)
2 diff
(99.8 %id)
TI_59382386   .a 79 to 991 102 to 1010       909/940
(96 %)
31 diff
(96.8 %id)
CA398133 eye, RPE/choroid .a 80 to 491 1 to 412   fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 412/412
(100 %)
0 diff
(100 %id)
AV658269 corresponding non cancerous liver tissue .a 80 to 445 1 to 366     Submitted on the opposite strand 366/367
(99 %)
1 diff
(99.8 %id)
AV658279 corresponding non cancerous liver tissue .a 80 to 445 1 to 366     Submitted on the opposite strand 366/366
(100 %)
2 diff
(99.5 %id)
AV658307 corresponding non cancerous liver tissue .a 80 to 690 1 to 610     Submitted on the opposite strand 610/615
(99 %)
18 diff
(97.1 %id)
BG388347 embryonal carcinoma, cell line, testis .a 80 to 879 1 to 803       803/939
(85 %)
16 diff
(98.3 %id)
BY796912 eye .a 81 to 694 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BU169384 eye, retinoblastoma .a 81 to 802 1 to 725       725/793
(91 %)
4 diff
(99.5 %id)
CX782756 human embryonic stem cells .a 81 to 914 1 to 834       834/834
(100 %)
0 diff
(100 %id)
TI_57198583   .a 81 to 930 29 to 882       854/952
(89 %)
17 diff
(98.3 %id)
TI_57229927   .a 82 to 813 90 to 817       728/728
(100 %)
4 diff
(99.5 %id)
CX752378 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 83 to 820 1 to 737     Submitted on the opposite strand 737/737
(100 %)
1 diff
(99.9 %id)
CR600844 Placenta Cot 25-normalized .a 84 to 1953 1 to 1870   tiling clone,   1870/1870
(100 %)
0 diff
(100 %id)
AL544405 placenta, Placenta Cot 25-normalized .a 84 to 1060 1 to 968   fully sequenced,   968/968
(100 %)
8 diff
(99.2 %id)
BQ423291 embryonal carcinoma, cell line, testis .a 84 to 968 1 to 886       886/887
(99 %)
11 diff
(98.8 %id)
DR157129 human embryonic stem cells differentiated toan early endodermal cell type .a 84 to 778 1 to 695       695/695
(100 %)
0 diff
(100 %id)
DR760126 embryonic stem .a 84 to 789 1 to 706       706/706
(100 %)
0 diff
(100 %id)
BQ270358 insulinoma, Pancreas .a 87 to 661 8 to 582       575/582
(98 %)
6 diff
(99.0 %id)
CV805922 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 87 to 868 1 to 782       782/782
(100 %)
0 diff
(100 %id)
TI_154178369   .a 87 to 456 92 to 461   AAA   370/784
(47 %)
5 diff
(99.4 %id)
BI711154 insulinoma, Pancreas .a 90 to 718 11 to 639     Submitted on the opposite strand 629/632
(99 %)
6 diff
(99.1 %id)
TI_57239803   .a 96 to 903 25 to 831       807/831
(97 %)
10 diff
(98.8 %id)
BE256254 eye, retinoblastoma .a 99 to 677 1 to 579       579/579
(100 %)
0 diff
(100 %id)
CA943014 Pancreas, Purified pancreatic islet .a 115 to 491 1 to 377   fully sequenced,   377/377
(100 %)
0 diff
(100 %id)
BE733543 choriocarcinoma, placenta .a 116 to 882 1 to 764       764/803
(95 %)
20 diff
(97.6 %id)
TI_154145096   .a 122 to 712 78 to 669       592/631
(93 %)
29 diff
(95.5 %id)
R57233   .a 126 to 281 1 to 154       154/154
(100 %)
12 diff
(92.3 %id)
AI468891 lymph node, lymphoma, follicular mixed small and largecell .a 176 to 567 1 to 392     Submitted on the opposite strand 392/392
(100 %)
0 diff
(100 %id)
AI978722 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 189 to 527 130 to 469     Submitted on the opposite strand 340/469
(72 %)
7 diff
(98.6 %id)
TI_1243018535   .a 197 to 1107 919 to 5       915/921
(99 %)
10 diff
(99.0 %id)
CX788640 human embryonic stem cells .a 198 to 1074 1 to 877       877/877
(100 %)
0 diff
(100 %id)
TI_1242415930   .a 209 to 1110 911 to 8       904/920
(98 %)
24 diff
(97.4 %id)
DR763105 embryonic stem .a 227 to 1063 1 to 837       837/837
(100 %)
0 diff
(100 %id)
TI_149289451   .a 248 to 939 785 to 95       691/786
(87 %)
6 diff
(99.3 %id)
DB093391 testis .a 293 to 850 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AF083127 colon .a 301 to 1277 1 to 978       978/978
(100 %)
1 diff
(99.9 %id)
BM460441 eye, retinoblastoma .a 354 to 1221 1 to 873       873/1074
(81 %)
9 diff
(99.2 %id)
BQ051219 large cell carcinoma, lung .a 356 to 1346 1 to 1014       1014/1014
(100 %)
36 diff
(96.5 %id)
BE768539 prostate_tumor .a 363 to 710 354 to 9       346/354
(97 %)
5 diff
(98.6 %id)
CX787332 human embryonic stem cells .a 402 to 1122 1 to 721       721/721
(100 %)
0 diff
(100 %id)
CA398132 eye, RPE/choroid .a 430 to 975 551 to 6   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 546/551
(99 %)
0 diff
(100 %id)
CA942770 Pancreas, Purified pancreatic islet .a 430 to 964 535 to 1   fully sequenced,   535/535
(100 %)
1 diff
(99.9 %id)
BM741895 Ascites, stomach .a 434 to 1026 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BM751784 Ascites, stomach .a 434 to 1015 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM744350 Ascites, stomach .a 434 to 1064 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BM756863 Ascites, stomach .a 434 to 992 1 to 559       559/559
(100 %)
0 diff
(100 %id)
TI_154170383   .a 452 to 1017 79 to 648       570/1007
(56 %)
14 diff
(98.7 %id)
TI_1242417296   .a 463 to 1115 657 to 5       653/758
(86 %)
11 diff
(98.6 %id)
N26738 melanocyte .a 464 to 918 455 to 1       455/456
(99 %)
5 diff
(99.0 %id)
AI619624 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 464 to 939 504 to 27       478/504
(94 %)
28 diff
(94.5 %id)
TI_1242415932   .a 470 to 1424 1 to 953       953/958
(99 %)
18 diff
(98.2 %id)
BQ677323 melanotic melanoma, cell line, skin .a 485 to 1366 1 to 886       886/887
(99 %)
16 diff
(98.2 %id)
TI_1243023209   .a 488 to 1628 1194 to 60     Submitted on the opposite strand 1100/1276
(86 %)
22 diff
(98.3 %id)
CF139937 CNCAP(3)T-225 cell line, Prostate .a 503 to 910 1 to 408       408/408
(100 %)
6 diff
(98.6 %id)
TI_154170278   .a 510 to 1034 78 to 602       525/525
(100 %)
5 diff
(99.1 %id)
TI_154178553   .a 510 to 1331 64 to 880       817/818
(99 %)
16 diff
(98.1 %id)
TI_154178559   .a 510 to 1331 68 to 876   AAA   811/839
(96 %)
21 diff
(97.5 %id)
TI_154178662   .a 510 to 1365 76 to 927       852/862
(98 %)
24 diff
(97.3 %id)
TI_154178751   .a 510 to 1367 73 to 920       848/867
(97 %)
23 diff
(97.4 %id)
TI_154178847   .a 510 to 1383 73 to 942       870/873
(99 %)
34 diff
(96.2 %id)
TI_1242415230   .a 513 to 1628 1160 to 50     Submitted on the opposite strand 1111/1230
(90 %)
22 diff
(98.3 %id)
AW294627   .a 525 to 931 418 to 9   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 410/418
(98 %)
3 diff
(99.3 %id)
BY993779   .a 528 to 1235 1 to 708       708/708
(100 %)
3 diff
(99.6 %id)
AI493187 uterus .a 535 to 916 382 to 1       382/382
(100 %)
2 diff
(99.5 %id)
CX758625 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 536 to 1287 1 to 751     Submitted on the opposite strand 751/751
(100 %)
2 diff
(99.8 %id)
TI_1243020087   .a 553 to 1102 550 to 1       550/554
(99 %)
17 diff
(97.0 %id)
CX788102 human embryonic stem cells .a 556 to 1340 1 to 785       785/785
(100 %)
0 diff
(100 %id)
TI_1243017959   .a 585 to 1628 1095 to 59     Submitted on the opposite strand 1039/1203
(86 %)
12 diff
(99.1 %id)
CB217539 mandible, pooled .a 588 to 975 1 to 388   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 388/388
(100 %)
3 diff
(99.3 %id)
TI_57172012   .a 592 to 1479 29 to 905       877/909
(96 %)
18 diff
(98.1 %id)
CX869732 embryonic stem .a 600 to 1383 1 to 784   fully sequenced,   784/784
(100 %)
0 diff
(100 %id)
BF336443 colon .a 613 to 890 8 to 290       283/290
(97 %)
15 diff
(94.9 %id)
TI_154177678   .a 616 to 1479 68 to 935       868/872
(99 %)
27 diff
(97.0 %id)
ES308278 beard hair, skin .a 625 to 794 1 to 169       169/169
(100 %)
1 diff
(99.5 %id)
BQ716846 dorsal root ganglia .a 662 to 1660 1 to 1006       1006/1006
(100 %)
23 diff
(97.8 %id)
AW390661 stomach .a 675 to 1271 595 to 1       595/598
(99 %)
8 diff
(98.7 %id)
CB217538 mandible, pooled .a 681 to 975 318 to 25   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 294/318
(92 %)
0 diff
(100 %id)
BI333316 cervical carcinoma cell line, cervix .a 686 to 1505 1 to 822       822/823
(99 %)
9 diff
(99.0 %id)
TI_154162970   .a 692 to 1430 80 to 828   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 749/758
(98 %)
42 diff
(94.5 %id)
CX754225 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 698 to 1429 1 to 732     Submitted on the opposite strand 732/732
(100 %)
0 diff
(100 %id)
AW813494 stomach .a 713 to 1271 559 to 1       559/559
(100 %)
10 diff
(98.3 %id)
BM928805 hepatocellular carcinoma, cell line, Liver .a 726 to 1729 1 to 1013       1013/1020
(99 %)
22 diff
(97.9 %id)
TI_154171873   .a 733 to 1295 80 to 642       563/566
(99 %)
3 diff
(99.5 %id)
TI_154172990   .a 734 to 1217 86 to 570       485/1158
(41 %)
3 diff
(99.8 %id)
AW813504 stomach .a 760 to 1271 512 to 1       512/513
(99 %)
8 diff
(98.5 %id)
BE708518 head_neck .a 776 to 1072 303 to 7       297/303
(98 %)
0 diff
(100 %id)
CD171967 White Matter .a 776 to 1642 1 to 874       874/876
(99 %)
12 diff
(98.7 %id)
AW939351 denis_drash .a 779 to 1295 527 to 11     Submitted on the opposite strand 517/527
(98 %)
0 diff
(100 %id)
BE156245 head_neck .a 806 to 1255 461 to 13     Submitted on the opposite strand 449/461
(97 %)
3 diff
(99.4 %id)
FN166076 breast carcinoma .a 818 to 892 1 to 75       75/82
(91 %)
2 diff
(97.6 %id)
EC470443 Prostate .a 822 to 918 18 to 113       96/113
(84 %)
6 diff
(94.7 %id)
BM563913 blood, natural killer cells, cell line .a 850 to 1536 1 to 694       694/1226
(56 %)
12 diff
(99.1 %id)
BQ052082 blood, natural killer cells, cell line .a 851 to 1734 1 to 890       890/1083
(82 %)
12 diff
(98.9 %id)
AW610100 stomach .a 861 to 1080 220 to 1       220/220
(100 %)
1 diff
(99.6 %id)
BM476694 leiomyosarcoma, uterus .a 862 to 1701 1 to 848       848/1141
(74 %)
19 diff
(98.4 %id)
TI_1242415668   .a 866 to 1628 15 to 777       763/1147
(66 %)
7 diff
(99.4 %id)
BX109219 senescent fibroblast .a 895 to 1620 1 to 726       726/726
(100 %)
0 diff
(100 %id)
BE928522 colon .a 908 to 1106 216 to 18       199/217
(91 %)
0 diff
(100 %id)
BF095494 uterus_tumor .a 908 to 1269 384 to 23       362/389
(93 %)
0 diff
(100 %id)
BM753072 stomach .a 926 to 1496 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BG003224 placenta_normal .a 932 to 1514 585 to 1       585/591
(98 %)
17 diff
(97.2 %id)
CR599700 HeLa cells Cot 25-normalized .a 932 to 1950 1 to 1020       1020/1020
(100 %)
1 diff
(100.0 %id)
TI_57192030   .a 935 to 1446 47 to 562   AAA   516/794
(64 %)
12 diff
(98.5 %id)
BM479771 embryonal carcinoma, cell line, testis .a 955 to 1991 1 to 1038       1038/1039
(99 %)
31 diff
(97.1 %id)
BM696893 eye, lens .a 957 to 1378 1 to 422       422/422
(100 %)
2 diff
(99.6 %id)
DA404008 thalamus .a 961 to 1508 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
AW853158 colon .a 975 to 1222 300 to 53       248/300
(82 %)
1 diff
(99.7 %id)
BQ645240 hepatocellular carcinoma, cell line, Liver .a 987 to 1936 1 to 951       951/952
(99 %)
9 diff
(99.1 %id)
AL570548 placenta, Placenta Cot 25-normalized .a 1030 to 1953 921 to 1   fully sequenced,   921/921
(100 %)
4 diff
(99.6 %id)
FN176299 breast carcinoma .a 1033 to 1141 109 to 1     Submitted on the opposite strand 109/109
(100 %)
5 diff
(95.5 %id)
TI_154194878   .a 1083 to 1956 51 to 928       878/1109
(79 %)
31 diff
(97.3 %id)
BF355338 head_neck .a 1099 to 1361 267 to 1       267/277
(96 %)
6 diff
(97.9 %id)
AL516231 brain, neuroblastoma, neuroblastoma cells .a 1111 to 1968 854 to 1       854/854
(100 %)
12 diff
(98.6 %id)
AK025446   .a 1113 to 4130 1 to 3018   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 3018/3018
(100 %)
6 diff
(99.9 %id)
TI_154031099   .a 1126 to 1982 928 to 82   AAA   847/981
(86 %)
19 diff
(98.1 %id)
TI_154131692   .a 1126 to 1982 939 to 95   AAA   845/974
(86 %)
20 diff
(98.0 %id)
CR992825 T-Lymphocytes .a 1127 to 1901 1 to 775       775/775
(100 %)
1 diff
(99.9 %id)
BE748875 bone marrow, from acute myelogenous leukemia .a 1192 to 1911 722 to 1       722/1002
(72 %)
5 diff
(99.6 %id)
CN419988 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1195 to 1921 1 to 731       731/731
(100 %)
4 diff
(99.5 %id)
ES311579 frontal balding hair, skin .a 1204 to 1367 1 to 160       160/162
(98 %)
13 diff
(92.0 %id)
BM985257 lung .a 1210 to 1982 789 to 19   AAA   771/771
(100 %)
4 diff
(99.5 %id)
BE714682 head_neck .a 1221 to 1578 359 to 1       359/371
(96 %)
25 diff
(93.3 %id)
BU169675 large cell carcinoma, lung .a 1221 to 1982 809 to 42   AAA Submitted on the opposite strand 768/815
(94 %)
9 diff
(98.9 %id)
TI_149294918   .a 1225 to 1685 877 to 422       456/1036
(44 %)
0 diff
(100 %id)
GD156303   .a 1236 to 1355 6 to 125   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 120/131
(91 %)
3 diff
(97.8 %id)
BQ774608 Bone, Human Chondrosarcoma Cell Line .a 1237 to 1982 762 to 19   AAA   744/744
(100 %)
2 diff
(99.8 %id)
CA308435 Alveolar Macrophage, lung .a 1237 to 1996 774 to 17   AAA   758/758
(100 %)
2 diff
(99.8 %id)
BG575369 breast, mammary adenocarcinoma, cell line .a 1239 to 1991 13 to 766       754/776
(97 %)
6 diff
(99.3 %id)
BQ775958 Bone, Human Chondrosarcoma Cell Line .a 1248 to 1982 752 to 19   AAA   734/734
(100 %)
1 diff
(99.9 %id)
AW385309 leiomios .a 1250 to 1888 652 to 16       637/652
(97 %)
0 diff
(100 %id)
CN480092 Knee, Osteoarthritic Cartilage .a 1259 to 1982 740 to 19   AAA   722/726
(99 %)
2 diff
(99.8 %id)
DB572805 hypothalamus .a 1276 to 1994 1 to 718     Submitted on the opposite strand 718/720
(99 %)
7 diff
(99.1 %id)
CX782683 human embryonic stem cells .a 1298 to 1982 715 to 31   AAA   685/685
(100 %)
1 diff
(99.9 %id)
TI_149277416   .a 1305 to 1996 797 to 106   AAA   692/693
(99 %)
0 diff
(100 %id)
CA442790 Fibrosarcoma .a 1306 to 1982 695 to 19   AAA   677/677
(100 %)
0 diff
(100 %id)
BQ027135 Chondrosarcoma, Left Pubic Bone .a 1308 to 1982 693 to 19   AAA   675/675
(100 %)
0 diff
(100 %id)
CA421553 Bone, Enchondroma cell line .a 1315 to 1982 686 to 19   AAA   668/668
(100 %)
0 diff
(100 %id)
BM989693 lung, Metastatic Chondrosarcoma .a 1316 to 1983 686 to 19   AAA   668/668
(100 %)
0 diff
(100 %id)
BU629915 cell lines, Chondrosarcoma .a 1316 to 1982 683 to 19   AAA   665/665
(100 %)
2 diff
(99.7 %id)
BQ774920 Bone, Human Chondrosarcoma Cell Line .a 1317 to 1982 684 to 19   AAA   666/666
(100 %)
0 diff
(100 %id)
DB526808 testis .a 1330 to 1982 1 to 653     Submitted on the opposite strand 653/653
(100 %)
0 diff
(100 %id)
TI_154135874   .a 1339 to 1982 747 to 108   AAA   640/661
(96 %)
24 diff
(96.4 %id)
CX869652 embryonic stem .a 1353 to 1993 655 to 15   fully sequenced,   641/655
(97 %)
7 diff
(99.0 %id)
BU677652 lung .a 1353 to 1996 662 to 19   AAA   644/644
(100 %)
0 diff
(100 %id)
BU616620 Bone, Subchondral Bone .a 1353 to 1982 648 to 19   AAA   630/630
(100 %)
0 diff
(100 %id)
TI_154191066   .a 1395 to 2196 48 to 848       801/978
(81 %)
23 diff
(97.7 %id)
BQ267451 insulinoma, Pancreas .a 1409 to 1982 591 to 18   AAA   574/574
(100 %)
1 diff
(99.9 %id)
DC427085   .a 1419 to 1980 566 to 4       563/569
(98 %)
0 diff
(100 %id)
BG943017 blood .a 1476 to 1983 548 to 41   AAA   508/508
(100 %)
1 diff
(99.9 %id)
TI_157595075   .a 1491 to 1982 584 to 91   AAA   494/494
(100 %)
19 diff
(96.2 %id)
AJ711579 heart .a 1508 to 1688 182 to 1     Submitted on the opposite strand 182/182
(100 %)
2 diff
(99.0 %id)
DB527395 testis .a 1516 to 1980 1 to 465     Submitted on the opposite strand 465/467
(99 %)
2 diff
(99.6 %id)
DC426217   .a 1535 to 1982 449 to 1       449/449
(100 %)
2 diff
(99.6 %id)
TI_154007396   .a 1560 to 1983 508 to 85   AAA   424/965
(43 %)
0 diff
(100 %id)
BP385180 pancreatic islet .a 1620 to 1993 1 to 374     Submitted on the opposite strand 374/374
(100 %)
0 diff
(100 %id)
AA679478   .a 1632 to 1903 335 to 64       272/339
(80 %)
0 diff
(100 %id)
BU735479 eye, lens .a 1640 to 1982 361 to 19   AAA   343/343
(100 %)
0 diff
(100 %id)
AA197313   .a 1703 to 1996 314 to 21   AAA   294/294
(100 %)
0 diff
(100 %id)
BI710824 insulinoma, Pancreas .a 1802 to 2176 382 to 8     Submitted on the opposite strand 375/382
(98 %)
0 diff
(100 %id)
CN387725 embryonic stem cells, cell lines H1, H7, andH9 .a 1862 to 2311 1 to 450   tiling clone,   450/450
(100 %)
0 diff
(100 %id)
DA033164   .a 2053 to 2619 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AW799017 uterus .a 2058 to 2595 555 to 20       536/569
(94 %)
0 diff
(100 %id)
BQ775941 Bone, Human Chondrosarcoma Cell Line .a 2139 to 2777 18 to 655     Submitted on the opposite strand 638/655
(97 %)
6 diff
(99.1 %id)
AW887058 ovary .a 2551 to 3045 537 to 41       497/538
(92 %)
23 diff
(95.8 %id)
BU167110 melanotic melanoma, skin .a 2668 to 3504 1 to 843   tiling clone,   843/844
(99 %)
10 diff
(98.9 %id)
BE065453 breast .a 2886 to 3217 333 to 3     Submitted on the opposite strand 331/333
(99 %)
0 diff
(100 %id)
DA155250 amygdala .a 2908 to 3481 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
TI_154036439   .a 4193 to 5043 885 to 53   tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 833/963
(86 %)
22 diff
(97.8 %id)
BX111557 ovarian tumor, ovary .a 4199 to 4872 1 to 674   tiling clone,   674/674
(100 %)
2 diff
(99.8 %id)
AA426539 ovarian tumor, ovary .a 4199 to 4677 1 to 478   tiling clone, fully sequenced,   478/478
(100 %)
2 diff
(99.6 %id)
TI_159696593   .a 4284 to 5047 844 to 87   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 758/964
(78 %)
13 diff
(98.7 %id)
AF074987   .a 4490 to 5136 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
AA928506 pooled .a 4491 to 5035 545 to 1       545/545
(100 %)
2 diff
(99.7 %id)
R63355 placenta .a 4518 to 4777 1 to 261       261/268
(97 %)
3 diff
(98.9 %id)
BF000244 colon, colon tumor, RER+ .a 4532 to 5137 606 to 1   tiling clone,   606/606
(100 %)
1 diff
(99.9 %id)
AI142425 uterus .a 4559 to 5031 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
AW449062   .a 4559 to 5031 490 to 18   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 473/474
(99 %)
2 diff
(99.6 %id)
DB549715 hippocampus .a 4577 to 5047 1 to 471     Submitted on the opposite strand 471/471
(100 %)
1 diff
(99.8 %id)
AI150557   .a 4596 to 5033 439 to 2       438/439
(99 %)
0 diff
(100 %id)
AA972372 pooled .a 4598 to 5032 435 to 1       435/438
(99 %)
2 diff
(99.6 %id)
AA995512 2 pooled tumors (clear cell type), Kidney .a 4605 to 5033 431 to 3       429/431
(99 %)
0 diff
(100 %id)
W19266 senescent fibroblast .a 4610 to 5033 431 to 5       427/431
(99 %)
0 diff
(100 %id)
DB534555 hippocampus .a 4624 to 5047 1 to 424     Submitted on the opposite strand 424/424
(100 %)
1 diff
(99.8 %id)
CB121617 Liver .a 4627 to 5140 528 to 14     Submitted on the opposite strand 515/528
(97 %)
0 diff
(100 %id)
AA426643 ovarian tumor, ovary .a 4647 to 5033 387 to 1   fully sequenced,   387/387
(100 %)
1 diff
(99.8 %id)
AI399901 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4660 to 5032 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
AA542811 metastatic prostate bone lesion .a 4669 to 5052 398 to 15       384/406
(94 %)
0 diff
(100 %id)
FN074624 breast carcinoma .a 4741 to 4835 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
AI086111 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4812 to 5030 219 to 1       219/219
(100 %)
0 diff
(100 %id)
CA952592 Pancreas, Purified pancreatic islet .a 4820 to 5031 212 to 1       212/212
(100 %)
1 diff
(99.6 %id)
BC016362 Bone marrow, acute myelogenous leukemia .b 1 to 1341 1 to 1340   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1340/1357
(98 %)
7 diff
(99.5 %id)
BJ991335 hepatoblastoma .b 15 to 590 11 to 586       576/576
(100 %)
0 diff
(100 %id)
DC424832   .b 31 to 759 1 to 728       728/733
(99 %)
7 diff
(99.1 %id)
BJ991336 hepatoblastoma .b 1382 to 1921 540 to 1   tiling clone,   540/540
(100 %)
0 diff
(100 %id)
DC427587   .b 1399 to 1939 537 to 1   tiling clone,   537/539
(99 %)
10 diff
(98.2 %id)
AK295935 substantia nigra .c 1 to 1470 1 to 1470 exact tiling clone,   1470/1470
(100 %)
1 diff
(100.0 %id)
DC336957 substantia nigra .c 1 to 579 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BE888445 leiomyosarcoma, uterus .c 54 to 676 1 to 623       623/623
(100 %)
1 diff
(99.9 %id)
BF673466 Prostate .c 60 to 782 1 to 730       730/785
(92 %)
22 diff
(97.2 %id)
DC424528 ovary, tumor tissue .c 62 to 647 1 to 586   tiling clone,   586/589
(99 %)
4 diff
(99.4 %id)
DC427319 ovary, tumor tissue .c 1294 to 1834 538 to 1   tiling clone,   538/572
(94 %)
8 diff
(98.7 %id)
BX421698 T cells (Jurkat cell line) .d 1 to 1057 1 to 1046 K178X C300X K301N F302S S303V ... tiling clone, AAA   1046/1046
(100 %)
19 diff
(98.2 %id)
DB017601 esophageal, tumor tissue .d 571 to 1145 2 to 576   tiling clone, capped   575/575
(100 %)
3 diff
(99.5 %id)
DA422119 cervix .d 956 to 1523 2 to 570   tiling clone, capped   569/569
(100 %)
2 diff
(99.7 %id)
BX509118   .d 1263 to 1700 1 to 438   tiling clone,   438/438
(100 %)
1 diff
(99.8 %id)
DA864686 placenta .e 1 to 484 2 to 493 L43S T45D H46A C47L K48Q ... tiling clone, capped   492/492
(100 %)
10 diff
(98.0 %id)
DA222874 brain .f 1 to 520 2 to 521 exact tiling clone, capped   520/520
(100 %)
0 diff
(100 %id)
BM454497 embryonal carcinoma, cell line, testis .g 1 to 757 1 to 758 F30L S68T R79T R93K L102P ... tiling clone,   758/1050
(72 %)
21 diff
(98.0 %id)
BX093726 B-cell, chronic lymphotic leukemia .h-u 1 to 305 1 to 304 exact tiling clone, AAA   304/304
(100 %)
1 diff
(99.7 %id)
AW603007 breast .h-u 14 to 286 16 to 288 exact tiling clone,   273/293
(93 %)
7 diff
(97.7 %id)
BE076958 breast .h-u 14 to 286 29 to 301 exact     273/318
(85 %)
7 diff
(97.8 %id)
AW580597 head_neck .h-u 21 to 277 278 to 22 Q47L     257/278
(92 %)
0 diff
(100 %id)
AI380874 B-cell, chronic lymphotic leukemia .h-u 40 to 305 292 to 27 S41F AAA   266/272
(97 %)
5 diff
(98.2 %id)
DW436725 Liver .i 1 to 181 19 to 199 exact tiling clone, AAA   186/199
(93 %)
8 diff
(96.0 %id)
TI_57218603   Gene RSL1D1, variant not shown         This clone was ignored    
TI_149277418   Gene RSL1D1, variant not shown         This clone was ignored    
TI_149295134   Gene RSL1D1, variant not shown         This clone was ignored    
TI_154122951   Gene RSL1D1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI